N-[(1R,3S)-3-[(3aS,6aS)-1-acetyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-5-yl]cyclohexyl]-4-fluoro-7-methyl-1H-indole-2-carboxamide

ID: ALA5206271

PubChem CID: 168294259

Max Phase: Preclinical

Molecular Formula: C24H31FN4O2

Molecular Weight: 426.54

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N1CC[C@H]2CN([C@H]3CCC[C@@H](NC(=O)c4cc5c(F)ccc(C)c5[nH]4)C3)C[C@H]21

Standard InChI:  InChI=1S/C24H31FN4O2/c1-14-6-7-20(25)19-11-21(27-23(14)19)24(31)26-17-4-3-5-18(10-17)28-12-16-8-9-29(15(2)30)22(16)13-28/h6-7,11,16-18,22,27H,3-5,8-10,12-13H2,1-2H3,(H,26,31)/t16-,17+,18-,22+/m0/s1

Standard InChI Key:  BMQZZTFEYYPYNC-RQXXJAGISA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -4.6974   -0.9340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9828   -0.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2708   -0.9336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2708   -1.7588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9810   -2.1706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6974   -1.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4861   -2.0138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4861   -0.6786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0011   -1.3463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9828    0.3034    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9810   -2.9958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1759   -1.3463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7633   -0.6316    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7633   -2.0609    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0617   -0.6316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4743    0.0829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2995    0.0829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7121   -0.6317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2995   -1.3463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4744   -1.3463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7121    0.7975    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3766    1.5509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9896    2.1029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7038    1.6905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5324    0.8837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3167    2.2423    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1611    2.9096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9813    2.9958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1138    2.0287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6974    2.6122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3274    1.2317    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4185    1.2779    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.2749    2.5155    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  4  7  1  0
  3  8  1  0
  8  9  2  0
  9  7  1  0
  2 10  1  0
  5 11  1  0
  9 12  1  0
 12 13  1  0
 12 14  2  0
 15 13  1  1
 16 15  1  0
 17 16  1  0
 18 17  1  0
 19 18  1  0
 20 19  1  0
 15 20  1  0
 17 21  1  1
 22 21  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 21  1  0
 24 26  1  0
 23 27  1  0
 27 28  1  0
 28 26  1  0
 26 29  1  0
 29 30  1  0
 29 31  2  0
 24 32  1  1
 23 33  1  1
M  END

Alternative Forms

  1. Parent:

    ALA5206271

    ---

Associated Targets(Human)

SETD2 Tchem Histone-lysine N-methyltransferase SETD2 (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.54Molecular Weight (Monoisotopic): 426.2431AlogP: 3.21#Rotatable Bonds: 3
Polar Surface Area: 68.44Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.21CX LogP: 1.97CX LogD: -0.76
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.79Np Likeness Score: -0.75

References

1. Alford JS, Lampe JW, Brach D, Chesworth R, Cosmopoulos K, Duncan KW, Eckley ST, Kutok JL, Raimondi A, Riera TV, Shook B, Tang C, Totman J, Farrow NA..  (2022)  Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies.,  13  (7.0): [PMID:35859865] [10.1021/acsmedchemlett.2c00167]

Source